EUVIMEDEUVIMED entdecken
Validierungsstudie

Analytical method validation and feasibility of salivary pregabalin measurement in Japanese volunteers: A pilot study

Hina Itoi, Yoshito Gando, Takeo Yasu, Masayuki Kobayashi

Drug Discoveries & Therapeutics · 30.06.2026 · 20 (3) · 269-272

DOI: 10.5582/ddt.2026.01015 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 30.06.2026. Verfasst von Hina Itoi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacodynamics and Toxicology Analytics, Meiji Pharmaceutical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Drug Monitoring, Pregabalin, Saliva. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This pilot study evaluated whether salivary pregabalin concentrations reflect plasma levels in Japanese volunteers to support non‑invasive therapeutic drug monitoring (TDM). Four healthy adults received a single 75‑mg orally disintegrating tablet; unstimulated saliva and venous blood were collected 1 hour post‑dose using a standardized passive‑drool protocol with pre‑collection rinsing. Pregabalin was quantified by a high-performance liquid chromatography with fluorescence detection. The assay met bioanalytical performance criteria across both matrices (excellent linearity, recovery > 94.2%, precision ≤ 10%, stability within 5.2%). At 1 hour, median concentrations were 1.96 μg/mL (plasma) and 0.466 μg/mL (saliva). In paired analysis (n = 4), saliva and plasma showed a positive trend (r = 0.838, p = 0.298). Given the small sample size, these results are considered exploratory and demonstrate the feasibility of the analytical approach rather than providing definitive clinical evidence. Under standardized collection conditions, salivary pregabalin concentrations appear to yield clinically interpretable estimates of systemic exposure, warranting validation in larger, multi‑time‑point cohorts to establish actionable saliva‑to‑plasma conversion thresholds and evaluate clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringPregabalinSalivaAdultFemaleHumansMaleYoung AdultChromatography, High Pressure LiquidFeasibility StudiesJapanPilot ProjectsReproducibility of ResultsEast Asian People

Stichwörter der Autor:innen

Therapeutic drug monitoringfluorescence detectionhigh-performance liquid chromatographynoninvasive samplingplasmasaliva

Substanzen

Pregabalin

Autor:innen und Institutionen

  • Department of Clinical Pharmacodynamics and Toxicology Analytics, Meiji Pharmaceutical University, Tokyo, Japan.
  • Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
  • Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo, Japan.
  • Department of Hematology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.

Zitieren

APA

Itoi, H., Gando, Y., Yasu, T., & Kobayashi, M. (2026). Analytical method validation and feasibility of salivary pregabalin measurement in Japanese volunteers: A pilot study. Drug Discoveries & Therapeutics, 20(3), 269-272. https://doi.org/10.5582/ddt.2026.01015

Vancouver

Itoi H, Gando Y, Yasu T, Kobayashi M. Analytical method validation and feasibility of salivary pregabalin measurement in Japanese volunteers: A pilot study. Drug Discoveries & Therapeutics. 2026;20(3):269-272. doi:10.5582/ddt.2026.01015

BibTeX
@article{Itoi2026,
  author = {Itoi, Hina and Gando, Yoshito and Yasu, Takeo and Kobayashi, Masayuki},
  title = {Analytical method validation and feasibility of salivary pregabalin measurement in Japanese volunteers: A pilot study},
  journal = {Drug Discoveries & Therapeutics},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {269--272},
  doi = {10.5582/ddt.2026.01015}
}
Kostenlos starten →